Table 2.
Prognostic value of the nine genes in the GC patients of the TCGA cohort.
| Gene symbol | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | Coefficient | |
| CST2 | 1.113 (1.029–1.204) | 0.0075 | 1.083 (0.975–1.203) | 0.1359 | 0.0797 |
| AADAC | 1.074 (1.009–1.143) | 0.0244 | 1.112 (1.042–1.186) | 0.0015 | 0.1058 |
| SERPINE1 | 1.261 (1.133–1.403) | <0.0001 | 1.358 (1.179–1.564) | <0.0001 | 0.306 |
| COL8A1 | 1.115 (1.011–1.230) | 0.0289 | 0.612 (0.470–0.797) | 0.0003 | -0.4913 |
| SMPD3 | 0.883 (0.803–0.971) | 0.0100 | 0.917 (0.815–1.031) | 0.1460 | -0.0871 |
| ASPN | 1.143 (1.038–1.258) | 0.0063 | 1.296 (1.090–1.542) | 0.0034 | 0.2596 |
| ITGBL1 | 1.105 (1.025–1.192) | 0.0092 | 1.209 (1.042–1.404) | 0.0126 | 0.1901 |
| MAP7D2 | 1.068 (1.008–1.132) | 0.0268 | 1.064 (1.000–1.133) | 0.0512 | 0.0624 |
| PLEKHS1 | 0.912 (0.846–0.982) | 0.0148 | 0.937 (0.859–1.023) | 0.1466 | -0.0646 |